WSCM
GSK icon

Wellington Shields Capital Management’s GSK GSK Stock Holding History

Wellington Shields Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$163K Hold
3,103
– – 0.02% 266
2026
Q1 		$171K Hold
3,103
– – 0.03% 248
2025
Q4 		$152K Hold
3,103
– – 0.02% 255
2025
Q3 		$134K Buy
+3,103
New +$121K 0.02% 263
2024
Q4 		– Sell
-3,103
Closed -$127K – 315
2024
Q3 		$127K Hold
3,103
– – 0.02% 263
2024
Q2 		$119K Buy
3,103
+1
+0% +$42 0.02% 259
2024
Q1 		$133K Buy
3,102
+1
+0% +$41 0.03% 252
2023
Q4 		$115K Buy
3,101
+1
+0% +$36 0.01% 254
2023
Q3 		$112K Sell
3,100
-400
-11% -$14.2K 0.01% 254
2023
Q2 		$125K Hold
3,500
– – 0.02% 242
2023
Q1 		$125K Hold
3,500
– – 0.02% 250
2022
Q4 		$123K Hold
3,500
– – 0.01% 249
2022
Q3 		$103K Buy
3,500
+3,260
+1,358% +$124K 0.02% 252
2022
Q2 		$13K Hold
240
– – ﹤0.01% 293
2022
Q1 		$13K Buy
+240
New +$13K ﹤0.01% 309
2018
Q1 		– Sell
-6,320
Closed -$280K – 335
2017
Q4 		$280K Sell
6,320
-800
-11% -$37K 0.04% 286
2017
Q3 		$361K Hold
7,120
– – 0.06% 239
2017
Q2 		$384K Sell
7,120
-560
-7% -$29.9K 0.06% 241
2017
Q1 		$405K Sell
7,680
-160
-2% -$8.12K 0.07% 222
2016
Q4 		$377K Sell
7,840
-400
-5% -$19.8K 0.06% 229
2016
Q3 		$444K Buy
8,240
+880
+12% +$48.3K 0.08% 222
2016
Q2 		$399K Buy
7,360
+1,520
+26% +$80.1K 0.07% 229
2016
Q1 		$296K Buy
5,840
+1,360
+30% +$67.7K 0.05% 257
2015
Q4 		$226K Buy
+4,480
New +$228K 0.04% 276

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Wellington Shields Capital Management's GSK Position: Q2 2026 in Review

Wellington Shields Capital Management held its GSK (GSK) position steady in Q2 2026 at 3,103 shares worth $163K. The position accounts for 0.02% of the portfolio, ranked #266.

Wellington Shields Capital Management first reported a position in GSK in Q4 2015 and has held it in 24 quarters since. The position peaked at $444K in Q3 2016. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Wellington Shields Capital Management held 3,103 shares of GSK worth $163K as of Q2 2026.
  • Wellington Shields Capital Management left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.02% of Wellington Shields Capital Management's portfolio in Q2 2026, its #266 holding.
  • Wellington Shields Capital Management first reported a position in GSK in Q4 2015 and has held it in 24 quarters since.
  • Wellington Shields Capital Management's GSK position peaked at $444K in Q3 2016.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Wellington Shields Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.